Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 kollaGen II-xs Aids Joint Pain, Inflammation & Flexibility - Nutraceuticals World

What are you searching for?

Sign in
Research

kollaGen II-xs Aids Joint Pain, Inflammation & Flexibility

By: Lisa Olivo

, Rodman Media

kollaGen II-xs from Certified Nutraceuticals, Inc. was found to be safe and effective in treating joint inflammation, secondary mobility, as well as providing other beneficial effects, according to a new 60 day human clinical study.
 
In the trial, researchers selected 20 patients’ ages 17 years to 81 years (10 males / 10 females) with confirmed joint damage and cartilage injuries, diagnosed with imaging/scoping with low to high pain scales. The optimal dosage administered is 1500mg – 2500mg daily dietary supplement taken with citric juice on an empty stomach.
 
Supplementation with kollaGen II-xs produced a significant treatment response at seven days for flexibility (33.3% increase; P = 0.035) and at 60 days for general pain (91.6% reduction; P = 0.005), flexibility (68.5% increase; P = 0.004) and range of motion associated pain (76.1% reduction; P = 0.011). The substantial treatment response continued through 60 days for pain (78.8% reduction; P = 0.001). There were no adverse events reported during the study and the treatment was reported to be well tolerated by study participants.
 
It was concluded that kollaGen II-xs is a safe novel preparation when taken at a dosage of 500mg 4 times per day. The ingredient benefited joint inflammation and pain, flexibility, as well as supported arthritic participants (rheumatoid and osteoarthritis alike). As a result, kollaGen II-xs may be a viable treatment option for the management of joint and connective tissue disorders.
 
For more information: www.certifiednutra.com

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics